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Mechanical strain of glomerular mesangial cells in the pathogenesis of
glomerulosclerosis: clinical implications
Pedro Cortes, Bruce L. Riser, Jerry Yee and Robert G. Narins

Introduction
The pre-glomerular vasodilation that characterizes a
wide range of renal diseases allows delivery of a greater
fraction of normal or elevated systemic pressure to
glomerular capillaries. This glomerular hypertension
is, at the very least, a strong contributing force to the
glomerulosclerosis seen in many progressive nephropathies. How the physical force of high intraglomerular
pressure is translated into the biochemical process of
glomerular scar formation, i.e. extracellular matrix
( ECM ) accumulation, has until recently, been largely
unexplored.
In the following paragraphs, citing our work and
that of others, we will show that the mesangial cell
stretch provoked by capillaries distended by hypertension, triggers the release of cytokines, including transforming growth factor-beta ( TGF-b). The actions of
these cytokines are, at least in part, responsible for net
mesangial matrix synthesis. Thus, the mechanical strain
of hypertension spawns the injurious accumulation
of glomerular ECM which ultimately causes renal
insufficiency.

Glomerular pressure: a determinant of capillary
and mesangial expansion
Glomeruli in kidneys perfused and fixed in situ, have
a larger volume than glomeruli in immersion-fixed
specimens from non-perfused kidneys [1,2]. Preservation of glomerular pressure in the former setting presumably maintains expanded capillaries, implying the
presence of an intrinsic pliability that allows the
glomerulus to distend and contract. The characteristics
of glomerular elasticity or compliance, the property
that allows pressure to regulate volume, were not
defined until studies in isolated microperfused glomeruli
became possible [2,3]. These studies have demonstrated
that the glomerulus is indeed a highly elastic structure
capable of marked volume changes within 2–3 s of
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altering intraglomerular pressure. Further, the attainable degree of glomerular distension can be extensive.
Increasing capillary pressure from zero to physiological
levels expands normal glomeruli up to 30% of their
basal volume [4]. However under normal conditions,
because glomeruli are exposed to only small pulse
pressure variations and not to the low frequency,
moment-to-moment oscillations in systemic pressure,
volume remains stable [5]. This tight control of intraglomerular pressure is due to the very effective autoregulation provided by the contractile activity of the
afferent arteriole [6 ].
This autoregulatory glomerular protection is characteristically impaired in many models of progressive
renal disease, including the remnant and diabetic
kidney [6,7]. Continuous systemic blood pressure monitoring has shown that in addition to the increasing
mean arterial pressure, subtotal nephrectomy causes
marked augmentation of the moment-to-moment variations in pressure [8]. Therefore, impaired autoregulation allows for the intraglomerular transmission of
systemic pressure, resulting in wide swings in glomerular volume, an alteration which is further magnified
by arterial hypertension. Normal glomeruli with intact
autoregulation vary their moment-to-moment volume
by a mere 0.4%, while glomeruli from remnant kidneys
of hypertensive animals demonstrate variations of up
to 7.3% [4]. In addition, it has been shown that changes
in overall volume are associated with parallel variations
in all the glomerular structural components, including
the mesangial areas [4].

Mechanical strain imposed on mesangial cells
Located at the centre of the glomerular lobule, mesangial cells extend cytoplasmic projections which attach
to the peripheral basement membrane at the points
where it deflects from its pericapillary course and at
the perimesangeal areas [9]. With pressure-induced
glomerular expansion, the outward displacement of
these anchoring points caused by distending capillaries
and mesangium results in intense mesangial cell stretch.
It is therefore, anticipated that cyclic changes in
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Mediators of the mechanically-induced metabolic
change
How mesangial cell stretch leads to the deposition of
ECM is not precisely known, but recent studies have
identified the participation of specific growth factors.
Cyclic stretch of mesangial cells in culture is associated
with the over-expression and activation of the cytokine,
transforming growth factor-b1 ( TGF-b1) and the
upregulation of its specific receptors on mesangial
cells [12,13]. This is a highly relevant finding because
abundant in vivo and in vitro evidence points to the
participation of this cytokine in various forms of
glomerulosclerosis [14,15]. TGF-b1 neutralization
experiments during cycles of stretch–relaxation of mesangial cells incubated in media with high glucose
concentrations, have demonstrated that the accumulation of ECM products is mainly ascribable to this
growth factor [16 ]. However, the metabolic effects of
mechanical strain do not appear to be a result of TGFb1 action under conditions of physiological glucose
concentration, suggesting that other, as yet undefined
mediators may be at play. More recently a newly
identified prosclerotic cytokine, connective tissue
growth factor (CTGF ), has also been shown to be
upregulated in stretched mesangial cells, although it
remains unknown if its participation is essential for
the accumulation of ECM [17]. Since the actions of
TGF-b1 and CTGF appear to be intimately related,
concurrently stimulating the synthesis and deposition
of collagenous tissue, it is likely that they may act in
concert. In relation to the relevance of mesangial cell
mechanical strain in the pathogenesis of diabetic glomerulosclerosis, it is interesting that stretch-induced
upregulation of TGF-b1, its receptors and CTGF are
all accentuated in cultures exposed to a high glucose
concentration.
The cellular sensing mechanism that translates

mechanical force into biochemical changes, remains
largely unknown. Possible key components of this
translating system have been identified in terms of
their sequence of activation. Within 30 min following
cyclic stretch, mesangial cell phosphorylation of the
focal adhesion kinase, pp125FAK, is increased, suggesting that the points at which the cell anchors to its
substrate and possibly the cytoskeleton, are involved
in the early steps of the translating mechanism [18].
In addition, after only 5–30 min a significant stimulation of signalling cascades controlled by protein kinase
C [19] and mitogen-activated protein kinases [20] is
detectable. Therefore, even brief periods of glomerular
distension and mesangial cell strain may effectively
initiate a chain of events which, if perpetuated, alters
the deposition of ECM.

Control of glomerular volume
Because restriction of glomerular distension may be
pivotal in avoiding the progression of glomerular
sclerosing processes, studies of the pathophysiologic
factors which regulate glomerular volume have become
critical. Since intraglomerular pressure is an obvious
and major factor [4], it follows that perfusion pressure,
the autoregulatory capacity of the afferent arteriole
and the tone of the efferent arteriole, all play key roles
in determining the state of glomerular distension. In
this regard, it is important to note that calcium channel
blockers, while diminishing systemic pressure, tend to
dilate afferent arterioles [21]. The balance struck by
these drugs between diminishing perfusion pressure
and its oscillations and the prevalent afferent arteriolar
resistance will determine whether glomerular pressures
are favourably or unfavourably altered. Converting
enzyme inhibitors and angiotensin II-receptor blockers
may lower intraglomerular pressure by both decreasing
systemic pressure and inducing efferent arteriolar vasodilatation. In addition, these agents may also inhibit
the direct- or TGF-b1-mediated angiotensin II
enhancement of collagen deposition [22,23]. While
differences in action between these antihypertensive
agents exist, settings where afferent arteriolar autoregulation is totally absent, a major factor in alleviating
glomerular strain is the decrease in systemic pressure
and its oscillations, regardless of how this is achieved.
A second factor determining glomerular expansion
is the basal glomerular volume [4]. At any given
intraglomerular pressure, larger, hypertrophied glomeruli are more distensible than smaller glomeruli.
Although this effect could be the mere result of capillary lengthening, it is more likely related to increased
capillary wall tension resulting from the increased
radius of hypertrophied capillaries [24]. Consequently,
whether induced by nephron loss or diabetes, glomerular hypertrophy magnifies the deleterious effects
of altered glomerular haemodynamics. The only
maneuvers known to ameliorate this hypertrophy are
strict metabolic control of diabetes and protein restriction [25,26 ]. Whether calcium channel blockers may
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glomerular volume are associated with repeated episodes of mesangial cell stretch and relaxation.
The effects of cyclic stretch–relaxation of mesangial
cells has been investigated in tissue culture [2,10].
These studies demonstrated that mechanical strain
induces profound changes in the synthesis and catabolism of ECM components leading to their accumulation
in the cell layer and in the incubation medium.
Furthermore, the intensity of this metabolic change is
proportional to the degree of mechanical strain
imposed on the mesangial cell. Interestingly, the accumulation of ECM induced by cell stretch is markedly
enhanced when the ambient glucose concentration is
increased [10].
It logically follows from the above that haemodynamically induced glomerular expansion–contraction may stimulate mesangial ECM deposition and
mesangial expansion with the eventual development of
glomerulosclerosis [11]. In addition, the hyperglycaemia of diabetes mellitus may sensitize glomeruli
to these adverse metabolic effects of mechanical strain.
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Summary
Due to their elasticity, glomeruli will undergo excessive
expansion and repetitive cycles of distension–contraction under conditions of impaired glomerular pressure
autoregulation and systemic arterial hypertension.
These alterations in glomerular volume are associated
with mesangial cell stretch which in turn stimulates the
synthesis and deposition of ECM with eventual mesangial expansion and glomerulosclerosis. Hyperactivity
of growth factors with prosclerotic activity is an
important component in the translation of cellular
mechanical strain into the abnormal metabolism of
ECM components.
Although mesangial cell mechanical strain is
expected to occur in both remnant glomeruli and in
glomeruli of diabetic kidneys, quantitatively different
factors will determine the resultant metabolic consequences. In remnant glomeruli, the mechanical
stretch is intense, being accounted for largely by the
marked glomerular hypertrophy and increased glomerular compliance. In diabetic glomeruli, however, the
mechanical stretch is less prominent but its effect on
ECM synthesis is markedly aggravated by the presence
of hyperglycaemia.
There are presently no methods clinically available
to diminish the prosclerotic action of growth factors
at the glomerular level. In addition, there are no
effective means to specifically improve glomerular pressure autoregulation. Therefore, current therapies must
be aimed at decreasing systemic arterial pressure,
blocking angiotensin II action and reducing glomerular
hypertrophy. While there are effective drugs for the
treatment of hypertension and for angiotensin II inhibition, protein restriction is the only measure available
to diminish glomerular hypertrophy. Finally, in diabetes correction of systemic and glomerular hypertension should be coupled with strict glycaemic control

to correct both glomerular autoregulation and
increased ECM deposition.
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A third factor influencing glomerular distension is
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periods of the disease [10].
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glomerular rigidity by opposing the pressure-driven
expansion. However, direct assessment of this component has shown that its role is probably unimportant
because in angiotensin II-perfused glomeruli, only 4%
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the associated mesangial cell contraction [4].
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Aptamers: novel tools for specific intervention studies
Jürgen Floege, Tammo Ostendorf and Nebojša Janjić1
Division of Nephrology, Medical School, Hannover, Germany, and 1NeXstar Pharmaceuticals, Boulder, Colorado, USA

Specific intervention studies are a crucial requirement
to demonstrate the pathogenetic relevance of particular
molecules and to ultimately develop novel therapeutic
approaches to renal disease. Inhibition studies of cytokines or growth factors provide a good example of the
various approaches that have been employed in such
studies in vivo.
(i) Neutralizing antibodies. Generation of such antibodies is probably the easiest way to accomplish
intervention studies. Problems of neutralizing antibodies relate to their immunogenicity in heterologous systems and, more importantly, to non-specific
effects of immunoglobulins per se, which may be
difficult to control.
(ii) Natural or designed antagonists (e.g. extracellular
domains of receptors or receptor antagonists). An
elegant, yet laborious way, which requires the
expression of considerable amounts of recombinant protein.
(iii) Interference with cytokine or growth factor signalling. An attractive approach since many compounds that inhibit molecules involved in
signalling are simple chemical structures that can
easily be synthesized. A frequent problem of this
approach, however, is non-specificity of the intervention given the convergence of many signalling
pathways and/or toxic in vivo effects.
(iv) Targeted gene deletion. A laborious way to investigate the function of a mediator, which also suffers
from the potential problem that the ontogenetic
lack of a single gene might have induced compensatory mechanisms that blunt the effects of the
deficiency.
Correspondence and offprint requests to: Jürgen Floege MD, Division of Nephrology 6840, Medizinische Hochschule, D-30623
Hannover, Germany.

(v) Antisense or ribozyme studies. While the compounds are relatively easy to synthesize, they
unfortunately have to enter the cell in order to
act. This renders in vivo studies difficult as the
compounds usually have to be transfected in vivo
using liposomes or viral vectors.
(vi) Specific interventions with aptamers.

What is an aptamer?
The term ‘aptamer’ was originally proposed by
Ellington and Szostak based on the latin word aptus,
i.e. to fit [1]. It describes the property of DNA or
RNA oligonucleotides to specifically bind to other
molecules outside or inside of cells. Thus, in this case
biological effects of the oligonucleotide are not a
function of the DNA or RNA code (as involved in
transcription and translation) but rather reside in the
specific three-dimensional structure of the oligonucleotide [1,2]. Aptamers are usually 20–50mers with
distinct structural elements (such as stems, loops,
pseudoknots, helix junctions, G-quartets etc.) that
create a stable framework in which some invariant
nucleotides are precisely arranged [3–5]. It is these
nucleotides at specific positions in the threedimensional structure that are central to the physicochemical interaction of the aptamer with other molecules. K -values for the interaction of aptamers with
d
their targets extend from the micromolar to low picomolar range and are therefore comparable in terms of
binding affinity to antibody–antigen interactions [3–5].
An impressive example of how seemingly minor
changes in an oligonucleotide sequence can have dramatic effects on the specificity of an aptamer is given
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